Vietnam has made history with the first AI product in the country to meet FDA standards for mammogram analysis. The US Food and Drug Administration (FDA) officially approved VinDr on May 23, making Vietnam the fifth country to have an AI product for mammography diagnosis approved by the FDA.
VinBigdata’s VinDr has been researched and evaluated using data sets from various target groups in both the US and Vietnam. The product can automatically classify mammograms, detect suspected cases of breast cancer, and has an accuracy of 96.5% with Vietnamese data and 95.8% with American data. Dr. Nguyen Quy Ha, Director of VinBigdata’s Image Analysis Technology Department, explained that while AI is widely used in medical image diagnosis and early cancer screening globally, it is still limited in Vietnam. VinDr aims to provide doctors with more information to prescribe in-depth tests and detect diseases promptly.
In addition to mammograms, VinDr is also equipped with smart diagnostic support tools for six other types of images including chest X-ray, spine X-ray, brain CT, chest CT, CT hepatobiliary, and MRI brain. The AI technology can detect and localize nearly 70 common types of abnormalities and diagnose multiple scans simultaneously with consistent accuracy and speed. Professor Vu Ha Van, Scientific Director of VinBigdata has been focusing on using AI in reading medical images and received FDA approval as a significant milestone for the company to enter the global market.
The development team behind VinDr has published 20 articles in international journals, including in Nature Scientific Data, a leading publication in the industry. The product not only makes a significant impact in Vietnam but has also been deployed in markets like the US, Korea, India
